Cutaneous Merkel Cell Carcinoma — Trials

Cutaneous Merkel Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: H. Lee Moffitt Cancer Center and Research Institute
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00004922	Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors	completed	Phase 2	—	Memorial Sloan Kettering Cancer CenterOTHER	1	Jun 19, 2013	clinicaltrials
NCT00079131	Oblimersen in Treating Patients With Merkel Cell Carcinoma	completed	Phase 2	37	National Cancer Institute (NCI)NIH	1	Jun 4, 2013	clinicaltrials